PYC is also heavily backed by rich listers…
They don’t need to reach out for a “Top 40” when displaying the registry…
The top 20 holds about 60% the bulk of it in the top 4 ….
It was the same with NEU luckily i jumped in just before Lang but he offered everyone to follow at ? $0.013 ? Double up … PYC similar double up at $0.01 but that was before the real rich listers came in ….
It’s the same reason i suggested ANP double up would be a good move prior to it happening & then embraced it …. No rich listers but AEI & Platinum leading it was a good enough in ..
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-68
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
